Ribavirin up-regulates IL-12 p40 gene expression and restores IL-12 levels in Leishmania-treated PBMCs

Parasite Immunology

Volumn 27, Issue 12, 2005, Pages 447-451

  Conte, Enrico ^a,b   Modica, A ^a   Cacopardo, B ^a   Messina, L ^a   Nigro, L ^a   Messina, A ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Department of Biomedical Sciences   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12P40; LIPOPHOSPHOGLYCAN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NUCLEOSIDE ANALOG; PARASITE ANTIGEN; PHYTOHEMAGGLUTININ; RIBAVIRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEISHMANIA DONOVANI; LEISHMANIASIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; UPREGULATION;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, PROTOZOAN; CELLS, CULTURED; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; LEISHMANIA DONOVANI; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN SUBUNITS; RIBAVIRIN; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

DNA VIRUSES; LEISHMANIA DONOVANI;

EID: 27844547046     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2005.00796.x     Document Type: Article

References (32)

1. Fernandez H, Banks G & Smith R. Ribavirin: a clinical overview. Eur J Epidemiol 1986; 2: 1-14.
2. Shigeta S, Mori S, Baba M et al. Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6́-(R)-6́-C-methylneplanocin A against several ortho- and paramyxoviruses. Antimicrob Agents Chemother 1992; 36: 435-439.
3. Balzarini J, Lee CK, Schols D & De Clercq E. 1-beta-D-ribofuranosyl- 1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D- ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2́,3́-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes. Biochem Biophys Res Commun 1991; 178: 563-569.
4. Tam RC, Pai B, Bard J et al. Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. J Hepatol 1999; 30: 376-382.
5. Trinchieri G, Pflanz S & Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003; 19: 641-644.
6. Kobayashi M, Fitz L, Ryan M et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827-845.
7. Stern AS, Podlaski FJ, Hulmes JD et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990; 87: 6808-6812.
8. Wolf SF, Temple PA, Kobayashi M et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991; 146: 3074-3081.
9. Gubler U, Chua AO, Schoenhaut DS et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991; 88: 4143-4147.
10. Mattner F, Magram J, Ferrante J et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996; 26: 1553-1559.
11. Magram J, Connaughton SE, Warrier RR et al. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996; 4: 471-481.
12. Cooper AM, Magram J, Ferrante J & Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997; 186: 39-45.
13. Muller U, Kohler G, Mossmann H et al. IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18. J Immunol 2001; 167: 3346-3353.
14. Piedrafita D, Proudfoot L, Nikolaev AV et al. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur J Immunol 1999; 29: 235-244.
15. Feng GJ, Goodridge HS, Harnett MM et al. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol 1999; 163: 6403-6412.
16. Lo SK, Bovis L, Matura R et al. Leishmania lipophosphoglycan reduces monocyte transendothelial migration: modulation of cell adhesion molecules, intercellular junctional proteins, and chemoattractants. J Immunol 1998; 160: 1857-1865.
17. Awasthi A, Mathur RK & Saha B. Immune response to Leishmania infection. Indian J Med Res 2004; 119: 238-258.
18. Zwingenberger K, Harms G, Pedrosa C, Omena S, Sandkamp B & Neifer S. Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production. Clin Immunol Immunopathol 1990; 57: 242-249.
19. Spellberg B & Edwards JE Jr. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 2001; 32: 76-102.
20. Wilson ME, Jeronimo SM & Pearson RD. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog 2005; 38: 147-160.
21. Holaday BJ, Pompeu MM, Jeronimo S et al. Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest 1993; 92: 2626-2632.
22. Alexander J & Bryson K. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 2005; 99: 17-23.
23. Cenini P, Berhe N, Hailu A, McGinnes K & Frommel D. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J Infect Dis 1993; 168: 986-993.
24. Salaiza-Suazo N, Volkow P, Tamayo R et al. Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome. Trop Med Int Health 1999; 4: 801-811.
25. Cacopardo B, Nigro L, Preiser W et al. Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans R Soc Trop Med Hyg 1996; 90: 434-435.
26. Martin J, Navas S, Quiroga JA, Pardo M & Carreno V. Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine 1998; 10: 635-644.
27. Carrera L, Gazzinelli RT, Badolato R et al. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996; 183: 515-526.
28. Amaraa R, Mareckova H, Urbanek P & Fucikova T. Production of interleukins 10 and 12 by activated peripheral blood monocytes/macrophages in patients suffering from chronic hepatitis C virus infection with respect to the response to interferon and ribavirin treatment. Immunol Lett 2002; 83: 209-214.
29. Shiina M, Kobayashi K, Satoh H, Niitsuma H, Ueno Y & Shimosegawa T. Ribavirin upregulates interleukin-12 receptor and induces T cell differentiation towards type 1 in chronic hepatitis C. J Gastroenterol Hepatol 2004; 19: 558-564.
30. Fang SH, Hwang LH, Chen DS & Chiang BL. Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. J Hepatol 2000; 33: 791-798.
31. Barnes E, Salio M, Cerundolo V et al. Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrob Agents Chemother 2004; 48: 3382-3389.
32. Kemp M, Kurtzhals JA, Kharazmi A & Theander TG. Interferon-gamma and interleukin-4 in human Leishmania donovani infections. Immunol Cell Biol 1993; 71: 583-587.